article thumbnail

Why should pharma invest in digital products for those living with rare diseases?

pharmaphorum

If you are a specialist rare disease pharma company, investing now in digital solutions will help you secure a “first to market” position that will increase your chances of being recognised as the favourable solution for HCPs and patients.